Antares Pharma To Present At The Stifel Nicolaus 2012 Healthcare Conference
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6, 2012 at 8:35 am Eastern Time.
A live webcast of the presentation will be available via the “Investor Relations” page of the Antares website, www.antarespharma.com. A replay of the webcast will also be archived on Antares’ website for 90 days following the presentation.
About Antares Pharma
Antares Pharma focuses on self-injection pharmaceutical products and
topical gel-based medicines. The Company's subcutaneous and
intramuscular injection technology platforms include Vibex™ disposable
pressure-assisted auto injectors, disposable multi-use pen injectors and
Vision™ reusable needle-free injectors marketed as Tjet
® and
Zomajet
® by Teva Pharmaceutical Industries, Ltd (Teva) and
Ferring Pharmaceuticals (Ferring), respectively. In the injector area,
Antares Pharma has a multi-product deal with Teva that includes
Tev-Tropin
® human growth hormone (hGH) and a partnership with
Ferring that includes Zomacton
® hGH. In the gel-based area,
the Company's FDA approved product is Gelnique 3%™ for the treatment of
OAB (overactive bladder) marketed by Watson Pharmaceuticals, Inc. in the
U.S. Antares’ portfolio includes Elestrin
® (estradiol gel)
indicated for the treatment of moderate-to-severe vasomotor symptoms
associated with menopause, and marketed in the U.S. by Jazz
Pharmaceuticals. Antares Pharma has two facilities in the U.S. The
Parenteral Products Group located in Minneapolis, Minnesota directs the
manufacturing and marketing of the Company’s reusable needle-free
injection devices and related disposables, and develops its disposable
pressure-assisted auto injector and pen injector systems. The Company’s
corporate offices and Pharma Group are located in Ewing, New Jersey,
where pharmaceutical products are developed utilizing both the Company’s
transdermal systems and drug/device combination products.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
